AW
LGND icon

Avion Wealth’s Ligand Pharmaceuticals LGND Stock Holding History

Avion Wealth’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2K Hold
9
– – ﹤0.01% 1064
2026
Q2 		$2K Hold
9
– – ﹤0.01% 1080
2026
Q1 		$1K Hold
9
– – ﹤0.01% 1078
2025
Q4 		$1K Hold
9
– – ﹤0.01% 1070
2025
Q3 		$1K Hold
9
– – ﹤0.01% 1041
2025
Q2 		$1K Hold
9
– – ﹤0.01% 1000
2025
Q1 		$0 Buy
+9
New +$1.02K ﹤0.01% 1216
2024
Q4 		– Sell
-9
Closed – – 1165
2024
Q3 		$0 Hold
9
– – ﹤0.01% 1197
2024
Q2 		$0 Hold
9
– – ﹤0.01% 1120
2024
Q1 		$1K Hold
9
– – ﹤0.01% 993
2023
Q4 		$1K Buy
+9
New +$531 ﹤0.01% 856

Other funds holding LGND

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Avion Wealth's LGND Position: Q3 2026 in Review

Avion Wealth held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 9 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Avion Wealth first reported a position in LGND in Q4 2023 and has held it in 11 quarters since. 246 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Avion Wealth held 9 shares of Ligand Pharmaceuticals worth $2K as of Q3 2026.
  • Avion Wealth left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #1064 holding.
  • Avion Wealth first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 246 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.